PET-CT-Based Auto-Contouring in Non-Small-Cell Lung Cancer Correlates With Pathology and Reduces Interobserver Variability in the Delineation of the Primary Tumor and Involved Nodal Volumes

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 3, 2007, Pages 771-778

  van Baardwijk, Angela ^a   Bosmans, Geert ^a   Boersma, Liesbeth ^a   Buijsen, Jeroen ^a   Wanders, Stofferinus ^a   Hochstenbag, Monique ^a   van Suylen, Robert Jan ^a   Dekker, André ^a   Dehing Oberije, Cary ^a   Houben, Ruud ^a   Bentzen, Søren M ^b   van Kroonenburgh, Marinus ^a   Lambin, Philippe ^a   De Ruysscher, Dirk ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Auto contouring; Interobserver variability; NSCLC; Pathology; PET CT

Indexed keywords

CELLS; CORRELATION METHODS; PATHOLOGY; PATIENT TREATMENT;

AUTO CONTOURING; CONCORDANCE INDEX (CI); GROSS TUMOR VOLUME (GTV); INTEROBSERVER VARIABILITY;

TUMORS;

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LUNG NON SMALL CELL CANCER; LYMPH NODE; OBSERVER VARIATION; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

ARTIFICIAL INTELLIGENCE; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; MALE; OBSERVER VARIATION; PATTERN RECOGNITION, AUTOMATED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34249275726     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.067     Document Type: Article

References (48)

1. Novello S., and le Chevalier T. Is there a standard strategy in the management of locally advanced non-small cell lung cancer?. Lung Cancer 34 Suppl. 4 (2001) S9-S14
2. Sause W., Kolesar P., Taylor S.I., et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 117 (2000) 358-364
3. Ataman O.U., Bentzen S.M., Saunders M.I., et al. Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis. Br J Cancer 85 (2001) 1113-1118
4. Cox J.D., Azarnia N., Byhardt R.W., et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 8 (1990) 1543-1555
5. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
6. Hazuka M.B., Turrisi III A.T., Lutz S.T., et al. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: A retrospective multivariate analysis. Int J Radiat Oncol Biol Phys 27 (1993) 273-284
7. Kong F.M., Ten Haken R.K., Schipper M.J., et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 324-333
8. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 24 (1999) 31-37
9. Onishi H., Kuriyama K., Yamaguchi M., et al. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: A good local response but no good survival due to radiation pneumonitis. Lung Cancer 40 (2003) 79-84
10. Ashamalla H., Rafla S., Parikh K., et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1016-1023
11. Bowden P., Fisher R., Mac Manus M., et al. Measurement of lung tumor volumes using three-dimensional computer planning software. Int J Radiat Oncol Biol Phys 53 (2002) 566-573
12. Court L.E., Dong L., Taylor N., et al. Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: An intra- and interobserver study. Int J Radiat Oncol Biol Phys 59 (2004) 412-418
13. Geets X., Daisne J.F., Arcangeli S., et al. Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: Comparison between CT-scan and MRI. Radiother Oncol 77 (2005) 25-31
14. Hurkmans C.W., Borger J.H., Pieters B.R., et al. Variability in target volume delineation on CT scans of the breast. Int J Radiat Oncol Biol Phys 50 (2001) 1366-1372
15. Riegel A.C., Berson A.M., Destian S., et al. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. Int J Radiat Oncol Biol Phys 65 (2006) 726-732
16. Saarnak A.E., Boersma M., van Bunningen B.N., et al. Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer. Radiother Oncol 56 (2000) 37-42
17. Tai P., Van Dyk J., Yu E., et al. Variability of target volume delineation in cervical esophageal cancer. Int J Radiat Oncol Biol Phys 42 (1998) 277-288
18. Van de Steene J., Linthout N., de Mey J., et al. Definition of gross tumor volume in lung cancer: Inter-observer variability. Radiother Oncol 62 (2002) 37-49
19. Yamamoto M., Nagata Y., Okajima K., et al. Differences in target outline delineation from CT scans of brain tumours using different methods and different observers. Radiother Oncol 50 (1999) 151-156
20. Bradley J., Thorstad W.L., Mutic S., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59 (2004) 78-86
21. Bujenovic S. The role of positron emission tomography in radiation treatment planning. Semin Nucl Med 34 (2004) 293-299
22. Ciernik I.F., Dizendorf E., Baumert B.G., et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. Int J Radiat Oncol Biol Phys 57 (2003) 853-863
23. De Ruysscher D., Wanders S., Minken A., et al. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study. Radiother Oncol 77 (2005) 5-10
24. De Ruysscher D., Wanders S., van Haren E., et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: A prospective clinical study. Int J Radiat Oncol Biol Phys 62 (2005) 988-994
25. Dizendorf E.V., Baumert B.G., von Schulthess G.K., et al. Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. J Nucl Med 44 (2003) 24-29
26. Kalff V., Hicks R.J., MacManus M.P., et al. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: A prospective study. J Clin Oncol 19 (2001) 111-118
27. Kiffer J.D., Berlangieri S.U., Scott A.M., et al. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 19 (1998) 167-177
28. Mah K., Caldwell C.B., Ung Y.C., et al. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study. Int J Radiat Oncol Biol Phys 52 (2002) 339-350
29. Steenbakkers R.J., Duppen J.C., Fitton I., et al. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: A 'Big Brother' evaluation. Radiother Oncol 77 (2005) 182-190
30. van Baardwijk A., Baumert B.G., Bosmans G., et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat Rev 32 (2006) 245-260
31. Caldwell C.B., Mah K., Ung Y.C., et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: The impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 51 (2001) 923-931
32. Fox J.L., Rengan R., O'Meara W., et al. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?. Int J Radiat Oncol Biol Phys 62 (2005) 70-75
33. Steenbakkers R.J., Duppen J.C., Fitton I., et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysis. Int J Radiat Oncol Biol Phys 64 (2006) 435-448
34. Ciernik I.F., Huser M., Burger C., et al. Automated functional image-guided radiation treatment planning for rectal cancer. Int J Radiat Oncol Biol Phys 62 (2005) 893-900
35. Daisne J.F., Sibomana M., Bol A., et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: Influence of reconstruction algorithms. Radiother Oncol 69 (2003) 247-250
36. Erdi Y.E., Mawlawi O., Larson S.M., et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 80 (1997) 2505-2509
37. Nestle U., Kremp S., Schaefer-Schuler A., et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med 46 (2005) 1342-1348
38. Daisne J.F., Duprez T., Weynand B., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233 (2004) 93-100
39. Thie J.A. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med 45 (2004) 1431-1434
40. De Leyn P., Stroobants S., De Wever W., et al. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: A Leuven Lung Cancer Group Study. J Clin Oncol 24 (2006) 3333-3339
41. Giraud P., Elles S., Helfre S., et al. Conformal radiotherapy for lung cancer: Different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother Oncol 62 (2002) 27-36
42. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983) 839-843
43. Bentzen S.M. High-tech in radiation oncology: Should there be a ceiling?. Int J Radiat Oncol Biol Phys 58 (2004) 320-330
44. Loo B.W., Quon A., Vasanawala M.S., et al. A method of target definition in PET-based radiotherapy planning. [Abstract]. Int J Radiat Oncol Biol Phys 60 (2004) S602
45. Birim O., Kappetein A.P., Stijnen T., et al. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg 79 (2005) 375-382
46. Luketich J.D., Friedman D.M., Meltzer C.C., et al. The role of positron emission tomography in evaluating mediastinal lymph node metastases in non-small-cell lung cancer. Clin Lung Cancer 2 (2001) 229-233
47. Vanuytsel L.J., Vansteenkiste J.F., Stroobants S.G., et al. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 55 (2000) 317-324
48. Stroom J., Blaauwgeers H., Belderbos J.S., et al. Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors (2005) Presented at the 8th Biennial ESTRO Meeting on Physics and Radiation Technology for Clinical Radiotherapy; September 24-29; Lisbon, Portugal.